Please login to the form below

Not currently logged in
Email:
Password:

job cuts

This page shows the latest job cuts news and features for those working in and with pharma, biotech and healthcare.

Pfizer drops neuroscience R&D, cutting 300 jobs

Pfizer drops neuroscience R&D, cutting 300 jobs

The job cuts will come mostly at its sites in Cambridge and Andover, Massachusetts, and in Groton, Connecticut, with about 100 losses expected at each.

Latest news

More from news
Approximately 45 fully matching, plus 91 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2013 Pharma deals during October 2013

    The month opened with the news that Merck &Co is eliminating a further 8, 500 jobs, in addition to the previously announced 7, 500 job cuts, in its plan to reduce

  • Partial privatisation shakes up pharma market in Spain Partial privatisation shakes up pharma market in Spain

    Pharma struggling with unpaid drug bills, price cuts and cost-containment measures amid upheaval of healthcare system. ... The reform is also expected to lead to significant job cuts (around 9, 000) in the public health sector, which will take place

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    Confronting mortality. Significant cuts may be on their way over the next four years, but Takeda and Nycomed have perhaps already come through the hardest parts of today's pharmaceutical environment.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics